Harnessing the Power of Purple Sweet Potato Color and Myo-Inositol to Treat Classic Galactosemia
Abstract
:1. Introduction
2. Results
3. Discussion
4. Materials and Methods
4.1. GalT Gene-Trapped (GalTKO) Mouse Model
4.2. Custom Diets
4.3. Hormone Analysis
4.4. Primary Fibroblast and Cell Culture Conditions
4.5. Immunofluorescence Studies
4.6. Follicle Counts
4.7. Breeding Trials
4.8. Liver Histology
4.9. GC-MS Quantification of Myo-Inositol in the Cerebellum
4.10. High-Performance Liquid Chromatography (HPLC)
4.11. Statistical Analysis
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Lai, K.; Langley, S.D.; Khwaja, F.W.; Schmitt, E.W.; Elsas, L.J. GALT deficiency causes UDP-hexose deficit in human galactosemic cells. Glycobiology 2003, 13, 285–294. [Google Scholar] [CrossRef] [PubMed]
- Waggoner, D.D.; Buist, N.R.; Donnell, G.N. Long-term prognosis in galactosaemia: Results of a survey of 350 cases. J. Inherit. Metab. Dis. 1990, 13, 802–818. [Google Scholar] [CrossRef] [PubMed]
- Berry, G.T. Classic Galactosemia and Clinical Variant Galactosemia. In GeneReviews(®); Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Stephens, K., Amemiya, A., Eds.; University of Washington: Seattle, WA, USA, 1993. [Google Scholar]
- Kuiper, A.; Grünewald, S.; Murphy, E.; Coenen, M.A.; Eggink, H.; Zutt, R.; Rubio-Gozalbo, M.E.; Bosch, A.M.; Williams, M.; Derks, T.G.J.; et al. Movement disorders and nonmotor neuropsychological symptoms in children and adults with classical galactosemia. J. Inherit. Metab. Dis. 2019, 42, 451–458. [Google Scholar] [CrossRef]
- Fridovich-Keil, J.L.; Gubbels, C.S.; Spencer, J.B.; Sanders, R.D.; Land, J.A.; Rubio-Gozalbo, E. Ovarian function in girls and women with GALT-deficiency galactosemia. J. Inherit. Metab. Dis. 2011, 34, 357–366. [Google Scholar] [CrossRef] [Green Version]
- Hadji, P. Menopausal symptoms and adjuvant therapy-associated adverse events. Endocr. Relat. Cancer 2008, 15, 73–90. [Google Scholar] [CrossRef] [PubMed]
- Tao, X.Y.; Zuo, A.Z.; Wang, J.Q.; Tao, F.B. Effect of primary ovarian insufficiency and early natural menopause on mortality: A meta-analysis. Climacteric 2016, 19, 27–36. [Google Scholar] [CrossRef] [PubMed]
- Rubio-Gozalbo, M.E.; Haskovic, M.; Bosch, A.M.; Burnyte, B.; Coelho, A.I.; Cassiman, D.; Couce, M.L.; Dawson, C.; Demirbas, D.; Derks, T.; et al. The natural history of classic galactosemia: Lessons from the GalNet registry. Orphanet J. Rare Dis. 2019, 14, 86. [Google Scholar] [CrossRef] [Green Version]
- Welsink-Karssies, M.M.; Schrantee, A.; Caan, M.W.A.; Hollak, C.E.M.; Janssen, M.C.H.; Oussoren, E.; de Vries, M.C.; Roosendaal, S.D.; Engelen, M.; Bosch, A.M. Gray and white matter are both affected in classical galactosemia: An explorative study on the association between neuroimaging and clinical outcome. Mol. Genet. Metab. 2020, 131, 370–379. [Google Scholar] [CrossRef]
- Nelson, M.D., Jr.; Wolff, J.A.; Cross, C.A.; Donnell, G.N.; Kaufman, F.R. Galactosemia: Evaluation with MR imaging. Radiology 1992, 184, 255–261. [Google Scholar] [CrossRef]
- Waisbren, S.E.; Rones, M.; Read, C.Y.; Marsden, D.; Levy, H.L. Brief report: Predictors of parenting stress among parents of children with biochemical genetic disorders. J. Pediatr. Psychol. 2004, 29, 565–570. [Google Scholar] [CrossRef]
- Groff, A.A.; Covington, S.N.; Halverson, L.R.; Fitzgerald, O.R.; Vanderhoof, V.; Calis, K.; Nelson, L.M. Assessing the emotional needs of women with spontaneous premature ovarian failure. Fertil. Steril. 2005, 83, 1734–1741. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Longo, N.; Price, L.B.; Gappmaier, E.; Cantor, N.L.; Ernst, S.L.; Bailey, C.; Pasquali, M. Anaplerotic therapy in propionic acidemia. Mol. Genet. Metab. 2017, 122, 51–59. [Google Scholar] [CrossRef] [PubMed]
- Unita, S.; Hirashima, N.; Shimada, M.; Tsunekawa, T.; Tanaka, D.; Kondo, T.; Urata, N.; Kondo, H.; Saito, M.; Iwase, H.; et al. Successful treatment of adult-onset type II citrullinemia with a low-carbohydrate diet and L-arginine after DNA analysis produced a definitive diagnosis. Clin. J. Gastroenterol. 2020, 13, 823–833. [Google Scholar] [CrossRef] [PubMed]
- Prasun, P. Multiple Acyl-CoA Dehydrogenase Deficiency. In GeneReviews(®); Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Stephens, K., Amemiya, A., Eds.; University of Washington: Seattle, WA, USA, 1993. [Google Scholar]
- Colhoun, H.O.; Rubio Gozalbo, E.M.; Bosch, A.M.; Knerr, I.; Dawson, C.; Brady, J.; Galligan, M.; Stepien, K.; O’Flaherty, R.; Catherine Moss, C.; et al. Fertility in classical galactosaemia, a study of N-glycan, hormonal and inflammatory gene interactions. Orphanet J. Rare Dis. 2018, 13, 164. [Google Scholar] [CrossRef] [PubMed]
- Coman, D.J.; Murray, D.W.; Byrne, J.C.; Rudd, P.M.; Bagaglia, P.M.; Doran, P.D.; Treacy, E.P. Galactosemia, a single gene disorder with epigenetic consequences. Pediatr. Res. 2010, 67, 286–292. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Forges, T.; Monnier-Barbarino, P.; Leheup, B.; Jouvet, P. Pathophysiology of impaired ovarian function in galactosaemia. Hum. Reprod. Update 2006, 12, 573–584. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Maratha, A.; Colhoun, H.O.; Knerr, I.; Coss, K.P.; Doran, P.; Treacy, E.P. Classical Galactosaemia and CDG, the N-Glycosylation Interface. A Review. JIMD Rep. 2017, 34, 33–42. [Google Scholar] [CrossRef] [Green Version]
- Balakrishnan, B.; Chen, W.; Tang, M.; Huang, X.; Cakici, D.D.; Siddiqi, A.; Berry, G.; Lai, K. Galactose-1 phosphate uridylyltransferase (GalT) gene: A novel positive regulator of the PI3K/Akt signaling pathway in mouse fibroblasts. Biochem. Biophys. Res. Commun. 2016, 470, 205–212. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Slepak, T.I.; Tang, M.; Slepak, V.Z.; Lai, K. Involvement of endoplasmic reticulum stress in a novel Classic Galactosemia model. Mol. Genet. Metab. 2007, 92, 78–87. [Google Scholar] [CrossRef] [Green Version]
- Jumbo-Lucioni, P.P.; Hopson, M.L.; Hang, D.; Liang, Y.; Jones, D.P.; Fridovich-Keil, J.L. Oxidative stress contributes to outcome severity in a Drosophila melanogaster model of classic galactosemia. Dis. Model. Mech. 2013, 6, 84–94. [Google Scholar] [CrossRef] [Green Version]
- Balakrishnan, B.; Siddiqi, A.; Mella, J.; Lupo, A.; Li, E.; Hollien, J.; Johnson, J.; Lai, K. Salubrinal enhances eIF2alpha phosphorylation and improves fertility in a mouse model of Classic Galactosemia. Biochim. Biophys. Acta Mol. Basis Dis. 2019, 1865, 165516. [Google Scholar] [CrossRef] [PubMed]
- Hagen-Lillevik, S.J.; Rushing, J.S.; Appiah, L.; Longo, N.; Andrews, A.; Lai, K.; Johnson, J. Pathophysiology and Management of Classic Galactosemic primary ovarian insufficiency. Reprod. Fertil. 2021, 2, R67–R84. [Google Scholar] [CrossRef]
- Llerena Cari, E.; Hagen-Lillevik, S.; Giornazi, A.; Post, M.; Komar, A.A.; Appiah, L.; Bitler, B.; Polotsky, A.J.; Santoro, N.; Kieft, J.; et al. Integrated stress response control of granulosa cell translation and proliferation during normal ovarian follicle development. Mol. Hum. Reprod. 2021, 27, gaab050. [Google Scholar] [CrossRef] [PubMed]
- Slepak, T.; Tang, M.; Addo, F.; Lai, K. Intracellular galactose-1-phosphate accumulation leads to environmental stress response in yeast model. Mol. Genet. Metab. 2005, 86, 360–371. [Google Scholar] [CrossRef] [PubMed]
- Pakos-Zebrucka, K.; Koryga, I.; Mnich, K.; Ljujic, M.; Samali, A.; Gorman, A.M. The integrated stress response. EMBO Rep. 2016, 17, 1374–1395. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Komar, A.A.; Merrick, W.C. A Retrospective on eIF2A-and Not the Alpha Subunit of eIF2. Int. J. Mol. Sci. 2020, 21, 2054. [Google Scholar] [CrossRef] [Green Version]
- Chen, W.; Caston, R.; Balakrishnan, B.; Siddiqi, A.; Parmar, K.; Tang, M.; Feng, M.; Lai, K. Assessment of ataxia phenotype in a new mouse model of galactose-1 phosphate uridylyltransferase (GALT) deficiency. J. Inherit. Metab. Dis. 2017, 40, 131–137. [Google Scholar] [CrossRef] [Green Version]
- Balakrishnan, B.; Nicholas, C.; Siddiqi, A.; Chen, W.; Bales, E.; Feng, M.; Johnson, J.; Lai, K. Reversal of aberrant PI3K/Akt signaling by Salubrinal in a GalT-deficient mouse model. Biochim. Biophys. Acta Mol. Basis Dis. 2017, 1863, 3286–3293. [Google Scholar] [CrossRef]
- Bizzarri, M.; Fuso, A.; Dinicola, S.; Cucina, A.; Bevilacqua, A. Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease. Expert Opin Drug Metab. Toxicol. 2016, 12, 1181–1196. [Google Scholar] [CrossRef] [PubMed]
- Santamaria, A.; Alibrandi, A.; Di Benedetto, A.; Pintaudi, B.; Corrado, F.; Facchinetti, F.; D’Anna, R. Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: A secondary analysis from 3 RCTs. Am. J. Obstet. Gynecol. 2018, 219, 300.e1–300.e6. [Google Scholar] [CrossRef] [PubMed]
- Mancini, M.; Andreassi, A.; Salvioni, M.; Pelliccione, F.; Mantellassi, G.; Banderali, G. Myoinositol and D-Chiro Inositol in Improving Insulin Resistance in Obese Male Children: Preliminary Data. Int. J. Endocrinol. 2016, 2016, 8720342. [Google Scholar] [CrossRef] [Green Version]
- Suda, I.; Ishikawa, F.; Hatakeyama, M.; Miyawaki, M.; Kudo, T.; Hirano, K.; Ito, A.; Yamakawa, O.; Horiuchi, S. Intake of purple sweet potato beverage affects on serum hepatic biomarker levels of healthy adult men with borderline hepatitis. Eur. J. Clin. Nutr. 2008, 62, 60–67. [Google Scholar] [CrossRef] [Green Version]
- The Effect of Purple Sweet Potato (PSP)-Juice on Liver Enzymes and Blood Pressure. Available online: https://ClinicalTrials.gov/show/NCT00962195 (accessed on 10 May 2022).
- Timson, D.J. Purple sweet potato colour––a potential therapy for galactosemia? Int. J. Food Sci. Nutr. 2014, 65, 391–393. [Google Scholar] [CrossRef] [PubMed]
- Timson, D.J. Repurposing drugs for the treatment of galactosemia. Expert Opin. Orphan Drugs 2019, 7, 443–451. [Google Scholar] [CrossRef]
- Esatbeyoglu, T.; Rodríguez-Werner, M.; Schlösser, A.; Winterhalter, P.; Rimbach, G. Fractionation, enzyme inhibitory and cellular antioxidant activity of bioactives from purple sweet potato (Ipomoea batatas). Food Chem. 2017, 221, 447–456. [Google Scholar] [CrossRef]
- Hwang, Y.P.; Choi, J.H.; Choi, J.M.; Chung, Y.C.; Jeong, H.G. Protective mechanisms of anthocyanins from purple sweet potato against tert-butyl hydroperoxide-induced hepatotoxicity. Food Chem. Toxicol. 2011, 49, 2081–2089. [Google Scholar] [CrossRef]
- Li, J.; Shi, Z.; Mi, Y. Purple sweet potato color attenuates high fat-induced neuroinflammation in mouse brain by inhibiting MAPK and NF-κB activation. Mol. Med. Rep. 2018, 17, 4823–4831. [Google Scholar] [CrossRef]
- Lu, J.; Wu, D.M.; Zheng, Y.L.; Hu, B.; Zhang, Z.F. Purple sweet potato color alleviates D-galactose-induced brain aging in old mice by promoting survival of neurons via PI3K pathway and inhibiting cytochrome C-mediated apoptosis. Brain Pathol. 2010, 20, 598–612. [Google Scholar] [CrossRef]
- Shan, Q.; Lu, J.; Zheng, Y.; Li, J.; Zhou, Z.; Hu, B.; Zhang, Z.; Fan, S.; Mao, Z.; Wang, Y.J.; et al. Purple sweet potato color ameliorates cognition deficits and attenuates oxidative damage and inflammation in aging mouse brain induced by d-galactose. J. Biomed. Biotechnol. 2009, 2009, 564737. [Google Scholar] [CrossRef]
- Caputo, M.; Bona, E.; Leone, I.; Samà, M.T.; Nuzzo, A.; Ferrero, A.; Aimaretti, G.; Marzullo, P.; Prodam, F. Inositols and metabolic disorders: From farm to bedside. J. Tradit. Complement. Med. 2020, 10, 252–259. [Google Scholar] [CrossRef]
- Wojciechowska, A.; Osowski, A.; Jozwik, M.; Gorecki, R.; Rynkiewicz, A.; Wojtkiewicz, J. Inositols’ Importance in the Improvement of the Endocrine-Metabolic Profile in PCOS. Int. J. Mol. Sci. 2019, 20, 5787. [Google Scholar] [CrossRef] [Green Version]
- Chhetri, D.R. Myo-Inositol and Its Derivatives: Their Emerging Role in the Treatment of Human Diseases. Front. Pharmacol. 2019, 10, 1172. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chatree, S.; Thongmaen, N.; Tantivejkul, K.; Sitticharoon, C.; Vucenik, I. Role of Inositols and Inositol Phosphates in Energy Metabolism. Molecules 2020, 25, 5079. [Google Scholar] [CrossRef]
- Berry, G.T. The role of polyols in the pathophysiology of hypergalactosemia. Eur. J. Pediatr. 1995, 154, S53–S64. [Google Scholar] [CrossRef]
- Berry, G.T. Is prenatal myo-inositol deficiency a mechanism of CNS injury in galactosemia? J. Inherit. Metab. Dis. 2011, 34, 345–355. [Google Scholar] [CrossRef] [PubMed]
- Kiani, A.K.; Paolacci, S.; Calogero, A.E.; Cannarella, R.; Di Renzo, G.C.; Gerli, S.; Della Morte, C.; Busetto, G.M.; De Berardinis, E.; Del Giudice, F.; et al. From Myo-inositol to D-chiro-inositol molecular pathways. Eur. Rev. Med. Pharmacol. Sci. 2021, 25, 2390–2402. [Google Scholar] [CrossRef]
- Lepore, E.; Lauretta, R.; Bianchini, M.; Mormando, M.; Di Lorenzo, C.; Unfer, V. Inositols Depletion and Resistance: Principal Mechanisms and Therapeutic Strategies. Int. J. Mol. Sci. 2021, 22, 6796. [Google Scholar] [CrossRef]
- He, J.; Giusti, M.M. Anthocyanins: Natural colorants with health-promoting properties. Annu. Rev. Food Sci. Technol. 2010, 1, 163–187. [Google Scholar] [CrossRef]
- Jumbo-Lucioni, P.P.; Ryan, E.L.; Hopson, M.L.; Bishop, H.M.; Weitner, T.; Tovmasyan, A.; Spasojevic, I.; Batinic-Haberle, I.; Liang, Y.; Jones, D.P.; et al. Manganese-based superoxide dismutase mimics modify both acute and long-term outcome severity in a Drosophila melanogaster model of classic galactosemia. Antioxid. Redox Signal. 2014, 20, 2361–2371. [Google Scholar] [CrossRef] [Green Version]
- Vanoevelen, J.M.; van Erven, B.; Bierau, J.; Huang, X.; Berry, G.T.; Vos, R.; Coelho, A.I.; Rubio-Gozalbo, M.E. Impaired fertility and motor function in a zebrafish model for classic galactosemia. J. Inherit. Metab. Dis. 2018, 41, 117–127. [Google Scholar] [CrossRef] [Green Version]
- Tian, L.; Tan, Y.; Chen, G.; Wang, G.; Sun, J.; Ou, S.; Chen, W.; Bai, W. Metabolism of anthocyanins and consequent effects on the gut microbiota. Crit. Rev. Food Sci. Nutr. 2019, 59, 982–991. [Google Scholar] [CrossRef] [PubMed]
- Li, A.; Xiao, R.; He, S.; An, X.; He, Y.; Wang, C.; Yin, S.; Wang, B.; Shi, X.; He, J. Research Advances of Purple Sweet Potato Anthocyanins: Extraction, Identification, Stability, Bioactivity, Application, and Biotransformation. Molecules 2019, 24, 3816. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Moreira, P.I.; Smith, M.A.; Zhu, X.; Nunomura, A.; Castellani, R.J.; Perry, G. Oxidative stress and neurodegeneration. Ann. N. Y. Acad. Sci. 2005, 1043, 545–552. [Google Scholar] [CrossRef] [PubMed]
- Yang, H.; Xie, Y.; Yang, D.; Ren, D. Oxidative stress-induced apoptosis in granulosa cells involves JNK, p53 and Puma. Oncotarget 2017, 8, 25310–25322. [Google Scholar] [CrossRef] [Green Version]
- Menezo, Y.J.; Silvestris, E.; Dale, B.; Elder, K. Oxidative stress and alterations in DNA methylation: Two sides of the same coin in reproduction. Reprod. Biomed. Online 2016, 33, 668–683. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pizzino, G.; Irrera, N.; Cucinotta, M.; Pallio, G.; Mannino, F.; Arcoraci, V.; Squadrito, F.; Altavilla, D.; Bitto, A. Oxidative Stress: Harms and Benefits for Human Health. Oxid. Med. Cell. Longev. 2017, 2017, 8416763. [Google Scholar] [CrossRef]
- Tang, M.; Siddiqi, A.; Witt, B.; Yuzyuk, T.; Johnson, B.; Fraser, N.; Chen, W.; Rascon, R.; Yin, X.; Goli, H.; et al. Subfertility and growth restriction in a new galactose-1 phosphate uridylyltransferase (GALT)––Deficient mouse model. Eur. J. Hum. Genet. 2014, 22, 1172–1179. [Google Scholar] [CrossRef] [Green Version]
- Wu, D.M.; Lu, J.; Zheng, Y.L.; Zhou, Z.; Shan, Q.; Ma, D.F. Purple sweet potato color repairs d-galactose-induced spatial learning and memory impairment by regulating the expression of synaptic proteins. NeuroBiol. Learn. Mem. 2008, 90, 19–27. [Google Scholar] [CrossRef]
- Zhang, Z.F.; Lu, J.; Zheng, Y.L.; Wu, D.M.; Hu, B.; Shan, Q.; Cheng, W.; Li, M.Q.; Sun, Y.Y. Purple sweet potato color attenuates hepatic insulin resistance via blocking oxidative stress and endoplasmic reticulum stress in high-fat-diet-treated mice. J. Nutr. Biochem. 2013, 24, 1008–1018. [Google Scholar] [CrossRef]
- Carlomagno, G.; Nordio, M.; Chiu, T.T.; Unfer, V. Contribution of myo-inositol and melatonin to human reproduction. Eur. J. Obstet. Gynecol. Reprod. Biol. 2011, 159, 267–272. [Google Scholar] [CrossRef]
- Yan, Z.; Dai, Y.; Fu, H.; Zheng, Y.; Bao, D.; Yin, Y.; Chen, Q.; Nie, X.; Hao, Q.; Hou, D.; et al. Curcumin exerts a protective effect against premature ovarian failure in mice. J. Mol. Endocrinol. 2018, 60, 261–271. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Agarwal, A.; Aponte-Mellado, A.; Premkumar, B.J.; Shaman, A.; Gupta, S. The effects of oxidative stress on female reproduction: A review. Reprod. Biol. Endocrinol. 2012, 10, 49. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wells, W.W.; Pittman, T.A.; Wells, H.J.; Egan, T.J. The Isolation And Identification Of Galactitol From The Brains Of Galactosemia Patients. J. Biol. Chem. 1965, 240, 1002–1004. [Google Scholar] [CrossRef]
- Kania, E.; Roest, G.; Vervliet, T.; Parys, J.B.; Bultynck, G. IP(3) Receptor-Mediated Calcium Signaling and Its Role in Autophagy in Cancer. Front. Oncol. 2017, 7, 140. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Donnelly, N.; Gorman, A.M.; Gupta, S.; Samali, A. The eIF2alpha kinases: Their structures and functions. Cell. Mol. Life Sci. 2013, 70, 3493–3511. [Google Scholar] [CrossRef]
- Carlomagno, G.; Unfer, V. Inositol safety: Clinical evidences. Eur. Rev. Med. Pharmacol. Sci. 2011, 15, 931–936. [Google Scholar]
- Myo-Inositol for Infertility in PCOS. Available online: https://ClinicalTrials.gov/show/NCT04407754 (accessed on 12 November 2021).
- Witchel, S.F.; Oberfield, S.E.; Pena, A.S. Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment with Emphasis on Adolescent Girls. J. Endocr. Soc. 2019, 3, 1545–1573. [Google Scholar] [CrossRef] [PubMed]
- Schmidt, H.; Schwaller, B.; Eilers, J. Calbindin D28k targets myo-inositol monophosphatase in spines and dendrites of cerebellar Purkinje neurons. Proc. Natl. Acad. Sci. USA 2005, 102, 5850–5855. [Google Scholar] [CrossRef] [Green Version]
- Le Bouffant, R.; Boulben, S.; Cormier, P.; Mulner-Lorillon, O.; Bellé, R.; Morales, J. Inhibition of translation and modification of translation factors during apoptosis induced by the DNA-damaging agent MMS in sea urchin embryos. Exp. Cell Res. 2008, 314, 961–968. [Google Scholar] [CrossRef]
- Wu, L.L.; Russell, D.L.; Wong, S.L.; Chen, M.; Tsai, T.S.; St John, J.C.; Norman, R.J.; Febbraio, M.A.; Carroll, J.; Robker, R.L. Mitochondrial dysfunction in oocytes of obese mothers: Transmission to offspring and reversal by pharmacological endoplasmic reticulum stress inhibitors. Development 2015, 142, 681–691. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- SRI 2022: Scientific Abstracts. Reprod. Sci. 2022, 29, 1–335. [CrossRef] [PubMed]
- Marzban, H.; Del Bigio, M.R.; Alizadeh, J.; Ghavami, S.; Zachariah, R.M.; Rastegar, M. Cellular commitment in the developing cerebellum. Front. Cell. Neurosci. 2015, 8, 450. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhao, L.; Longo-Guess, C.; Harris, B.S.; Lee, J.W.; Ackerman, S.L. Protein accumulation and neurodegeneration in the woozy mutant mouse is caused by disruption of SIL1, a cochaperone of BiP. Nat. Genet. 2005, 37, 974–979. [Google Scholar] [CrossRef] [PubMed]
- Tessitore, A.; Martin, M.D.P.; Sano, R.; Ma, Y.; Mann, L.; Ingrassia, A.; Laywell, E.D.; Steindler, D.A.; Hendershot, L.M.; d’Azzo, A. GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Mol. Cell 2004, 15, 753–766. [Google Scholar] [CrossRef] [PubMed]
- Šišková, Z.; Reynolds, R.A.; O’Connor, V.; Perry, V.H. Brain region specific pre-synaptic and post-synaptic degeneration are early components of neuropathology in prion disease. PLoS ONE 2013, 8, e55004. [Google Scholar] [CrossRef]
- Gao, X.-R.; Chen, Z.; Fang, K.; Xu, J.-X.; Ge, J.-F. Protective effect of quercetin against the metabolic dysfunction of glucose and lipids and its associated learning and memory impairments in NAFLD rats. Lipids Health Dis. 2021, 20, 164. [Google Scholar] [CrossRef]
- Basaranoglu, M.; Turhan, N.; Sonsuz, A.; Basaranoglu, G. Mallory-Denk Bodies in chronic hepatitis. World J. Gastroenterol. 2011, 17, 2172–2177. [Google Scholar] [CrossRef] [PubMed]
- Lee, M.; Kim, D.; Park, S.J.; Kim, K.S.; Park, G.D.; Kim, O.K.; Lee, J. Artichoke Extract Directly Suppresses Inflammation and Apoptosis in Hepatocytes During the Development of Non-Alcoholic Fatty Liver Disease. J. Med. Food 2021, 24, 1058–1067. [Google Scholar] [CrossRef]
- Babu, P.V.; Liu, D.; Gilbert, E.R. Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J. Nutr. Biochem. 2013, 24, 1777–1789. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Aguirre, L.; Portillo, M.P.; Hijona, E.; Bujanda, L. Effects of resveratrol and other polyphenols in hepatic steatosis. World J. Gastroenterol. 2014, 20, 7366–7380. [Google Scholar] [CrossRef]
- Wallace, T.C.; Giusti, M.M. Anthocyanins. Adv. Nutr. 2015, 6, 620–622. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nair, A.B.; Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm. 2016, 7, 27–31. [Google Scholar] [CrossRef] [Green Version]
- Uslu, B.; Dioguardi, C.C.; Haynes, M.; Miao, D.Q.; Kurus, M.; Hoffman, G.; Johnson, J. Quantifying growing versus non-growing ovarian follicles in the mouse. J. Ovarian Res. 2017, 10, 3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Byers, S.L.; Wiles, M.V.; Dunn, S.L.; Taft, R.A. Mouse estrous cycle identification tool and images. PLoS ONE 2012, 7, e35538. [Google Scholar] [CrossRef] [Green Version]
- Batts, K.P.; Ludwig, J. Chronic hepatitis. An update on terminology and reporting. Am. J. Surg. Pathol. 1995, 19, 1409–1417. [Google Scholar] [CrossRef] [PubMed]
- Harborne, J.B.; Hall, E. Plant polyphenols-XIII.: The systematic distribution and origin of anthocyanins containing branched trisaccharides. Phytochemistry 1964, 3, 453–463. [Google Scholar] [CrossRef]
- Wheeler, L.C.; Walker, J.F.; Ng, J.; Deanna, R.; Dunbar-Wallis, A.; Backes, A.; Pezzi, P.H.; Palchetti, M.V.; Robertson, H.M.; Monaghan, A.; et al. Transcription Factors Evolve Faster Than Their Structural Gene Targets in the Flavonoid Pigment Pathway. Mol. Biol. Evol. 2022, 39, msac044. [Google Scholar] [CrossRef] [PubMed]
- Lai, K.; Boxer, M.B.; Marabotti, A. GALK inhibitors for classic galactosemia. Future Med. Chem. 2014, 6, 1003–1015. [Google Scholar] [CrossRef] [PubMed]
- Safety and Pharmacokinetics of AT-007 in Healthy Subjects and in Adult Subjects With Classic Galactosemia. Available online: https://ClinicalTrials.gov/show/NCT04117711 (accessed on 5 February 2022).
- Balakrishnan, B.; An, D.; Nguyen, V.; DeAntonis, C.; Martini, P.G.V.; Lai, K. Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia. Mol. Ther. 2020, 28, 304–312. [Google Scholar] [CrossRef] [PubMed]
- Rasmussen, S.A.; Daenzer, J.M.I.; Fridovich-Keil, J.L. A pilot study of neonatal GALT gene replacement using AAV9 dramatically lowers galactose metabolites in blood, liver, and brain and minimizes cataracts in GALT-null rat pups. J. Inherit. Metab. Dis. 2021, 44, 272–281. [Google Scholar] [CrossRef]
- Brophy, M.L.; Stansfield, J.C.; Ahn, Y.; Cheng, S.H.; Murphy, J.E.; Bell, R.D. AAV-mediated expression of galactose-1-phosphate uridyltransferase corrects defects of galactose metabolism in classic galactosemia patient fibroblasts. J. Inherit. Metab. Dis. 2022, 45, 481–492. [Google Scholar] [CrossRef] [PubMed]
- Daenzer, J.M.I.; Rasmussen, S.A.; Patel, S.; McKenna, J., 3rd; Fridovich-Keil, J.L. Neonatal GALT gene replacement offers metabolic and phenotypic correction through early adulthood in a rat model of classic galactosemia. J. Inherit. Metab. Dis. 2022, 45, 203–214. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Hagen-Lillevik, S.; Johnson, J.; Siddiqi, A.; Persinger, J.; Hale, G.; Lai, K. Harnessing the Power of Purple Sweet Potato Color and Myo-Inositol to Treat Classic Galactosemia. Int. J. Mol. Sci. 2022, 23, 8654. https://doi.org/10.3390/ijms23158654
Hagen-Lillevik S, Johnson J, Siddiqi A, Persinger J, Hale G, Lai K. Harnessing the Power of Purple Sweet Potato Color and Myo-Inositol to Treat Classic Galactosemia. International Journal of Molecular Sciences. 2022; 23(15):8654. https://doi.org/10.3390/ijms23158654
Chicago/Turabian StyleHagen-Lillevik, Synneva, Joshua Johnson, Anwer Siddiqi, Jes Persinger, Gillian Hale, and Kent Lai. 2022. "Harnessing the Power of Purple Sweet Potato Color and Myo-Inositol to Treat Classic Galactosemia" International Journal of Molecular Sciences 23, no. 15: 8654. https://doi.org/10.3390/ijms23158654